NR4A1 and breast cancer: Owing to its molecular heterogeneity, BC can be classified into distinct molecular subtypes based on the varying expression of hormone receptors i.e., estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER-2).